
Phaarmasia Ltd Valuation Shifts Signal Elevated Risk Amid Price Correction
2026-11-16 08:00:28Phaarmasia Ltd has witnessed a marked deterioration in its valuation parameters, shifting from a previously attractive profile to one now classified as risky. This change accompanies a sharp 7.85% drop in the stock price, reflecting growing investor concerns amid stretched price-to-earnings and price-to-book multiples compared to both historical levels and peer averages.
Read MorePhaarmasia Ltd Falls 3.35%: Key Financial Setbacks and Volatility Mark the Week
2026-11-15 10:00:09Key Events This Week Nov 09: Stock declines 2.99% to Rs.79.55 despite Sensex rising 0.48% Nov 11: Sharp rebound with 8.11% gain to Rs.86.00, outpacing Sensex’s 0.92% rise Nov 12: Stock holds steady at Rs.86.00 while Sensex gains 0.32% Nov 13: Stock plunges 7.85% to Rs.79.25 amid negative financial news; Sensex falls 0.46% Week OpenRs.82.00 <div cl...
Read More
Phaarmasia Ltd Reports Negative Financial Trend Amidst Volatile Market Performance
2026-11-13 11:00:31Phaarmasia Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a marked deterioration in its financial trend during the September 2026 quarter. Despite a recent surge in its share price, the company’s latest quarterly results reveal declining profitability and contracting revenues, signalling challenges ahead for investors amid a volatile market backdrop.
Read More
Phaarmasia Ltd is Rated Sell by MarketsMOJO
2026-10-27 10:11:20Phaarmasia Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 October 2026, providing investors with the most recent and relevant data to assess the company’s outlook.
Read More
Phaarmasia Ltd is Rated Sell by MarketsMOJO
2026-10-14 10:11:07Phaarmasia Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read More
Phaarmasia Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges
2026-10-05 08:00:46Phaarmasia Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive price range, despite ongoing sector headwinds. This revaluation, driven by improved price-to-earnings and price-to-book ratios relative to peers and historical averages, offers investors a fresh perspective on the micro-cap pharmaceutical player’s market positioning and potential.
Read More
Phaarmasia Ltd Upgraded to Sell on Improved Technicals and Valuation
2026-10-02 08:04:55Phaarmasia Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 October 2026, reflecting notable improvements in its technical outlook and valuation metrics despite ongoing challenges in financial performance. The micro-cap pharmaceutical company’s Mojo Score rose to 47.0, signalling a cautious but more optimistic stance among analysts.
Read More
Phaarmasia Ltd is Rated Strong Sell
2026-09-29 10:10:03Phaarmasia Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 04 September 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 29 September 2026, providing investors with the most recent and relevant data to assess the stock’s outlook.
Read More
Phaarmasia Ltd is Rated Strong Sell
2026-09-18 10:10:03Phaarmasia Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 04 September 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
14-Nov-2026 | Source : BSENewspaper Advertisement of the Unaudited Financial Results for the Quarter ended 30th september 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday 12Th November 2026 Held Through Video Conference
12-Nov-2026 | Source : BSEFinancial Results For The Quarter Ended 30Th September 2026 - Regulation 33(3)(A) Of SEBI (LODR) Regulations 2015
12-Nov-2026 | Source : BSEFinancial Results for the Quarter ended 30th september 2026 along with Limited Review Report
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available